Characteristics | Before propensity score matching | After propensity score matching | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
CBDCA+PEM | CBDCA+PTX | p-value | CBDCA+PEM | CBDCA+PTX | p-value | ||||||
(nā=ā135) | (nā=ā105) | Ā | (nā=ā94) | (nā=ā94) | Ā | ||||||
n | (%) | n | (%) | Ā | n | (%) | n | (%) | Ā | ||
Sex | Male | 84 | (62.2) | 89 | (84.8) | <ā0.001 | 78 | (83.0) | 78 | (83.0) | 1.000 |
Female | 51 | (37.8) | 16 | (15.2) | Ā | 16 | (17.0) | 16 | (17.0) | Ā | |
Age, years | <ā65 | 56 | (41.5) | 46 | (43.8) | 0.793 | 37 | (39.4) | 43 | (45.7) | 0.461 |
ā„65 | 79 | (58.5) | 59 | (56.2) | Ā | 57 | (60.6) | 51 | (54.3) | Ā | |
Motion sickness | No | 122 | (90.4) | 99 | (94.3) | 0.338 | 85 | (90.4) | 89 | (94.7) | 0.406 |
Yes | 13 | (9.6) | 6 | (5.7) | Ā | 9 | (9.6) | 5 | (5.3) | Ā | |
Drinking habit | No | 78 | (57.8) | 52 | (49.5) | 0.240 | 45 | (47.9) | 45 | (47.9) | 1.000 |
Yes | 57 | (42.2) | 53 | (50.5) | Ā | 49 | (52.1) | 49 | (52.1) | Ā | |
Number of antiemetics | 2 | 95 | (70.4) | 91 | (86.7) | 0.003 | 80 | (85.1) | 80 | (85.1) | 1.000 |
3 | 40 | (29.6) | 14 | (13.3) | Ā | 14 | (14.9) | 14 | (14.9) | Ā |